As the Trump administration explores a U.S. cryptocurrency stockpile, two Texas bills filed this session are looking to be at the forefront of establishing a strategic bitcoin reserve for the state.

US stocks dropped sharply Monday — and chipmaker Nvidia lost nearly $600 billion in market value — after a surprise advancement from a Chinese artificial intelligence company, DeepSeek, threatened the aura of invincibility surrounding America’s technology industry.

President Donald Trump ordered the creation of a digital asset working group on Thursday which, among other things, would be tasked with exploring a U.S. cryptocurrency stockpile.

Overnight, Texas Instruments reported an earnings beat, but offered a disappointing outlook sending that stock lower by 4.5% in premarket trading.

The price of Bitcoin (CRYPTO: BTC) soared 119% in 2024, and the bulls have been out in full force lately, making predictions about where the cryptocurrency is headed this year. Most recently ...

As you know, I am a bear on crypto. At this point, I think we are close to the top or perhaps may have even seen it. At the extreme end of my positive expectations, I am a minor bull with $120,000 ...

Bitcoin (BTC) fell below $100,000 for the first time since US President Donald Trump took office on Jan. 20 as global markets reacted to rising competition in the AI sector and shifting monetary ...

Business intelligence firm MicroStrategy has proposed a stock offering to raise cash for “general corporate purposes,” including acquiring more Bitcoin (BTC), signaling its intent to continue ...

Bitcoin's value rests mostly on its status as the first cryptocurrency and as an alternative to fiat currency, while Ethereum (Ether) offers more utilitarian value through its ecosystem of ...

From Barcelona's bustling streets to France's rich art history and London's music scene, creators are using bitcoin as both a medium and a muse. Here's how art brings its story to life ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President Donald Trump's administration following criticism from the pharmaceutical industry for the Biden-era law.

In this podcast, Motley Fool co-founder David Gardner is joined by superstar guests Randi Zuckerberg and Morgan Housel as they each share three stories -- one to educate, one to amuse, and one to enrich.